Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.28 | 1.4 |
NAV | ₹150.91 | ₹1901.79 |
Fund Started | 23 Sep 2005 | 08 Dec 1994 |
Fund Size | ₹1043.92 Cr | ₹69639.05 Cr |
Exit Load | Exit load of 0.25% if redeemed within 7 days. | Exit load of 1% if redeemed within 1 year
|
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 3.64% | 15.91% |
3 Year | 14.32% | 24.21% |
5 Year | 21.00% | 31.64% |
1 Year
3 Year
5 Year
Equity | 90.22% | 87.39% |
Cash | 9.78% | 11.01% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 9.63% |
ICICI Bank Ltd. | 8.99% |
Bharti Airtel Ltd. | 5.73% |
Reliance Industries Ltd. | 5.37% |
Infosys Ltd. | 4.81% |
ICICI Lombard General Insurance Company Ltd. | 4.20% |
Dr. Reddy's Laboratories Ltd. | 4.03% |
Kotak Mahindra Bank Ltd. | 3.97% |
TVS Motor Company Ltd. | 3.89% |
Gland Pharma Ltd. | 3.67% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 9.58% |
HDFC Bank Ltd. | 9.45% |
Axis Bank Ltd. | 8.86% |
Kotak Mahindra Bank Ltd. | 5.14% |
SBI Life Insurance Company Ltd. | 4.33% |
Maruti Suzuki India Ltd. | 4.14% |
Cipla Ltd. | 3.98% |
Bharti Airtel Ltd. | 3.19% |
HCL Technologies Ltd. | 2.74% |
Piramal Pharma Ltd. | 2.62% |
Name | Ashwin Jain | Dhruv Muchhal |
Start Date | 21 Oct 2024 | 14 Sep 2023 |
Name
Start Date
Description | The Scheme proposes to invest in equity and equity related securities. The portfolio will have no more than 30 stocks. | The scheme seeks to generate capital appreciation / income from a portfolio, predominantly invested in equity & equity related instruments. |
Launch Date | 23 Sep 2005 | 08 Dec 1994 |
Description
Launch Date